Requirements for empirical immunogenicity trials, rather than structure-based design, for developing an effective HIV vaccine

Algemeen

Stellenbosse Instituut vir Gevorderde Navorsing (SIGNA)

Please help us populate SUNScholar with the post print version of this article. It can be e-mailed to: scholar@sun.ac.za